| 标题 |
Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial |
| 网址 | |
| DOI |
10.1681/asn.2024yaqz098x
doi
|
| 其它 |
期刊:Journal of the American Society of Nephrology 作者:Zhao Cui; Zhang Yimiao; Heng Li; Hua Zhou; Hong Li Lin; et al 出版日期:2024-10-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)